IDEX Reports Fourth Quarter and Full Year 2023 Results

Fourth Quarter Highlights






Sales of $789 million, down 3% overall and 6% organically



Reported diluted EPS of $1.43, down 16%; adjusted diluted EPS of $1.83, down 9%



Strong operating cash...

Related Keywords

California ,United States ,Vermont ,America ,Abhi Khandelwal ,Eric Ashleman ,Ericd Ashleman ,Health Science Technologies ,Corporate Office ,York Stock Exchange ,Muon Group ,New York Stock Exchange ,Life Sciences ,Company Scientific Fluidics Optics ,Exchange Commission ,Health Science ,Material Solutions ,Chief Executive Officer ,Analytical Instrumentation ,Quarter Ended December ,Year Ended December ,Diluted Earnings ,Share Attributable ,Net Income ,Adjusted Diluted ,Metering Technologies ,Science Technologies ,Diversified Products ,Santa Ana ,Scientific Fluidics ,Executive Officer ,President Eric Ashleman ,Senior Vice President ,Chief Financial Officer Abhi Khandelwal ,Private Securities Litigation Reform Act ,Hurst Jaws ,Consolidated Statements ,Common Share ,Cash Flows ,Segment Financial Information ,Iridian Spectral Technologies ,Pipeline Renewal Technologies ,Consolidated Adjusted ,Net Sales ,Organic Net ,Reported To Adjusted Gross Profit ,Gross Margin ,Reported To Adjusted Net Income Attributable ,Adjusted Net Sales ,Operating Activities ,Free Cash Flow ,Markets ,